Clinical Trial Update: Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenvatinib plus paclitaxel in patients with advanced biliary tract cancer after gemcitabine-based therapy; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• LENVIMA (lenvatinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Advanced Biliary Tract Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING